Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -69.78% is 136% below its 5-year average of -29.59%, near the low end of its 5-year range (-106.19%–56.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.34% below its 12-month average of -59.98%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -69.78%.
RETURN ON EQUITY (ROE)
-69.78%
RETURN ON EQUITY (ROE) AVG TTM
-59.98%
RETURN ON EQUITY (ROE) AVG 3Y
-16.09%
RETURN ON EQUITY (ROE) AVG 5Y
-29.59%
RETURN ON EQUITY (ROE) AVG 10Y
-37.73%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.34%
CURRENT VS 3Y AVG
-333.64%
CURRENT VS 5Y AVG
-135.81%
CURRENT VS 10Y AVG
-84.97%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-66.11%
vs the sector median at left
Voyager Therapeutics, Inc.
Market Cap
$148.64M
Return on Equity (ROE)
-69.78%
TTM Avg
-59.98%
3Y Avg
-16.09%
5Y Avg
-29.59%
Market Cap
$148.73M
Return on Equity (ROE)
-131.85%
TTM Avg
-36.69%
3Y Avg
-135.43%
5Y Avg
-129.92%
Market Cap
$148.27M
Return on Equity (ROE)
-21.38%
TTM Avg
-42.33%
3Y Avg
-37.95%
5Y Avg
-45.57%
Market Cap
$149.36M
Return on Equity (ROE)
-59.40%
TTM Avg
-255.06%
3Y Avg
-160.44%
5Y Avg
-112.56%
Market Cap
$146.62M
Return on Equity (ROE)
-183.44%
TTM Avg
-114.28%
3Y Avg
-67.72%
5Y Avg
-46.03%
Market Cap
$146.28M
Return on Equity (ROE)
-93.22%
TTM Avg
-92.28%
3Y Avg
-73.94%
5Y Avg
-53.80%
Market Cap
$146.27M
Return on Equity (ROE)
68.12%
TTM Avg
-94.32%
3Y Avg
-166.28%
5Y Avg
-128.51%
Market Cap
$151.01M
Return on Equity (ROE)
-155.34%
TTM Avg
-168.75%
3Y Avg
-117.97%
5Y Avg
-104.46%
Market Cap
$152.72M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | $148.64M | -69.78% | -59.98% | -16.09% | -29.59% |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | -131.85% | -36.69% | -135.43% | -129.92% |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | -21.38% | -42.33% | -37.95% | -45.57% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | -59.40% | -255.06% | -160.44% | -112.56% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | -183.44% | -114.28% | -67.72% | -46.03% |
| Codexis, Inc. (CDXS)vs › | $146.28M | -93.22% | -92.28% | -73.94% | -53.80% |
| Fortress Biotech, Inc. (FBIOP)vs › | $146.27M | 68.12% | -94.32% | -166.28% | -128.51% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | -155.34% | -168.75% | -117.97% | -104.46% |
| Veraxa Biotech Holding AG (VRXA)vs › | $152.72M | N/A | N/A | N/A | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | -397.38% | -1100.28% | -310.11% | -250.84% |
ROE
-69.8%
ROA
-54.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -69.78% |
| 2026-03-31 | -67.16% |
| 2025-12-31 | -61.06% |
| 2025-09-30 | -57.67% |
| 2025-06-30 | -44.25% |
| 2025-03-31 | -31.06% |
| 2024-12-31 | -21.68% |
| 2024-09-30 | 7.84% |
| 2024-06-30 | 2.69% |
| 2024-03-31 | -0.89% |
| 2023-12-31 | 56.00% |
| 2023-09-30 | 29.68% |
| 2023-06-30 | 48.15% |
| 2023-03-31 | 45.61% |
| 2022-12-31 | -78.63% |
| 2022-09-30 | -21.39% |
| 2022-06-30 | -99.64% |
| 2022-03-31 | -93.33% |
| 2021-12-31 | -74.90% |
| 2021-09-30 | -106.19% |
| 2021-06-30 | 16.21% |
| 2021-03-31 | 28.89% |
| 2020-12-31 | 23.81% |
| 2020-09-30 | 24.12% |
| 2020-06-30 | -78.72% |
| 2020-03-31 | -51.02% |
| 2019-12-31 | -43.81% |
| 2019-09-30 | -49.52% |
| 2019-06-30 | -49.69% |
| 2019-03-31 | -94.87% |
| 2018-12-31 | -190.09% |
| 2018-09-30 | -118.20% |
| 2018-06-30 | -98.30% |
| 2018-03-31 | -75.20% |
| 2017-12-31 | -52.69% |
| 2017-09-30 | -86.31% |
| 2017-06-30 | -56.22% |
| 2017-03-31 | -40.47% |
| 2016-12-31 | -29.57% |
| 2016-09-30 | -22.00% |
| 2016-06-30 | -17.80% |
| 2016-03-31 | -13.62% |
| 2015-12-31 | -17.55% |
| 2015-09-30 | -26.62% |
| 2015-06-30 | -25.94% |
| 2015-03-31 | -58.77% |
